Schaeffer et al. suggested that IGF2BP3 was found to be selectively overexpressed in pancreatic ductal adenocarcinoma tissues but not in benign pancreatic tissues[37]. Here, IGF2BP3 is linked to pancreatic ductal adenocarcinoma.